Peripheral Blood Stem Cell TransplantationHematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation, HomologousHematopoietic Stem Cell MobilizationTransplantation ConditioningStem Cell TransplantationHematologic NeoplasmsGraft vs Host DiseaseLeukapheresisGranulocyte Colony-Stimulating FactorMelphalanAntigens, CD34Blood Component RemovalCombined Modality TherapyBone Marrow TransplantationGraft SurvivalCyclophosphamideHematopoietic Stem CellsBusulfanStem CellsMyeloablative AgonistsMultiple MyelomaTreatment OutcomeAntineoplastic Combined Chemotherapy ProtocolsCord Blood Stem Cell TransplantationEndothelial CellsTransplantation ChimeraRecurrenceTissue DonorsRemission InductionAntineoplastic Agents, AlkylatingLymphoma, Non-HodgkinEtoposideHistocompatibilityPOEMS SyndromeThiotepaWhole-Body IrradiationHistocompatibility TestingDisease-Free SurvivalInfectionTransplantation, IsogeneicImmunosuppressive AgentsVidarabineRetrospective StudiesHematopoiesisAmyloidosisSalvage TherapyLeukemiaTime FactorsIfosfamideSurvival RateVincristineBlood CellsSurvival AnalysisCarmustineGraft vs Leukemia EffectCells, CulturedCytarabineHodgkin DiseaseLeukemia, Myeloid, AcutePlatelet CountCytomegalovirus InfectionsMyelodysplastic SyndromesAnemia, AplasticBlood Cell CountLymphomaNeoplasmsCytophagocytosisLiver TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionFatal OutcomeLivedo ReticularisFeasibility StudiesHistiocytosis, Non-Langerhans-CellFollow-Up StudiesRecombinant ProteinsOpportunistic InfectionsHematologic DiseasesDoxorubicinCyclosporinePrecursor Cell Lymphoblastic Leukemia-LymphomaHLA AntigensBone MarrowBlood DonorsEndothelium, VascularImmunophenotypingAntigens, CDImmunosuppressionProspective StudiesMesenchymal Stem Cell TransplantationLymphoma, T-CellBone Marrow PurgingPilot ProjectsPrednisoneCarboplatinBone Marrow DiseasesFlow CytometryAntineoplastic Agents